Genetic Analysis and Follow-Up of 25 Neonatal Diabetes Mellitus Patients in China

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Cao, Bingyan ^a   Gong, Chunxiu ^a   Wu, Di ^a   Lu, Chaoxia ^b   Liu, Fang ^b   Liu, Xiaojing ^c   Zhang, Yingxian ^c   Gu, Yi ^a   Qi, Zhan ^a   Li, Xiaoqiao ^a   Liu, Min ^a   Li, Wenjing ^a   Su, Chang ^a   Liang, Xuejun ^a   Feng, Mei ^d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c ZHENGZHOU CHILDREN S HOSPITAL   (China)

^d ShanXi Children's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; EIF2AK3 PROTEIN; GLIBENCLAMIDE; GLIS3 PROTEIN; HEMOGLOBIN A1C; INS PROTEIN; PIG INSULIN; PROTEIN; SLC19A2 PROTEIN; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADOLESCENT; ANEMIA; ARTICLE; BONE DYSPLASIA; CHILD; CHINA; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL CATARACT; CONVULSION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENETIC ANALYSIS; GLYCEMIC CONTROL; GROWTH RETARDATION; HUMAN; HYPOTHYROIDISM; INFANT; INSULIN TREATMENT; KIDNEY FAILURE; LIVER DYSFUNCTION; MALE; MEDICAL RECORD REVIEW; MENTAL DEFICIENCY; MOLECULAR TYPING; MULTIFACTORIAL INHERITANCE; NEWBORN; NEWBORN DIABETES MELLITUS; PRIORITY JOURNAL; SHORT STATURE; DIABETES MELLITUS, TYPE 1; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; METABOLISM; MUTATION; PHENOTYPE; PROGNOSIS;

BLOOD GLUCOSE; CHINA; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; KATP CHANNELS; MALE; MUTATION; PHENOTYPE; PROGNOSIS;

EID: 84956937175     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/6314368     Document Type: Article

References (25)

1. E. L. Edghill and A. T. Hattersley, "Genetic disorders of the pancreatic beta cell and diabetes (permanent neonatal diabetes and maturity-onset diabetes of the young), " in Pancreatic Beta Cell in Health and Disease, S. Seino and G. I. Bell, Eds., pp. 389-420, Springer, Tokyo, Japan, 2008.
2. I. K. Temple, R. J. Gardner, D. J. G. Mackay, J. C. K. Barber, D. O. Robinson, and J. P. H. Shield, "Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes, " Diabetes, vol. 49, no. 8, pp. 1359-1366, 2000.
3. D. J. G. Mackay and I. K. Temple, "Transient neonatal diabetes mellitus type 1, " American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol. 154, no. 3, pp. 335-342, 2010.
4. A. P. Babenko, M. Polak, H. Cavé et al., "Activating mutations in the ABCC8 gene in neonatal diabetes mellitus, " The New England Journal of Medicine, vol. 355, no. 5, pp. 456-466, 2006.
5. A. L. Gloyn, E. R. Pearson, J. F. Antcliff et al., "Activating mutations in the gene encoding the ATP-sensitive potassiumchannel subunit Kir6. 2 and permanent neonatal diabetes, " The New England Journal ofMedicine, vol. 350, no. 18, pp. 1838-1849, 2004.
6. M. Vaxillaire, A. Bonnefond, and P. Froguel, "The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis, " Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 26, no. 2, pp. 171-187, 2012.
7. L. E. Docherty, S. Kabwama, A. Lehmann et al., "Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients, " Diabetologia, vol. 56, no. 4, pp. 758-762, 2013.
8. E. L. Edghill, S. E. Flanagan, A.-M. Patch et al., "Insulin mutation screening in 1, 044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood, " Diabetes, vol. 57, no. 4, pp. 1034-1042, 2008.
9. E. R. Pearson, I. Flechtner, P. R. NjØlstad et al., "Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6. 2 mutations, " The New England Journal of Medicine, vol. 355, no. 5, pp. 467-477, 2006.
10. G. Tonini, C. Bizzarri, R. Bonfanti et al., "Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6. 2) gene, " Diabetologia, vol. 49, no. 9, pp. 2210-2213, 2006.
11. InternationalDiabetes Federation, Global IDF/ISPADGuideline for Diabetes in Childhood and Adolescents, International Diabetes Federation, 2011.
12. C. Gong, S. Huang, C. Su et al., "Congenital hyperinsulinism in Chinese patients: 5-yr treatment outcome of 95 clinical cases with genetic analysis of 55 cases, " Pediatric Diabetes, 2015.
13. I. Salahshourifar, A. S. Halim, W. A. W. Sulaiman, and B. A. Zilfalil, "Maternal uniparental heterodisomy of chromosome 6 in a boy with an isolated cleft lip and palate, " American Journal of Medical Genetics Part A, vol. 152, no. 7, pp. 1818-1821, 2010.
14. K. Busiah, S. Drunat, L. Vaivre-Douret et al., "Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study, "TheLancetDiabetes&Endocrinology, vol. 1, no. 3, pp. 199-207, 2013.
15. T. Klupa, J. Skupien, B. Mirkiewicz-Sieradzka et al., "Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up, " Diabetes Technology & Therapeutics, vol. 12, no. 5, pp. 387-391, 2010.
16. S. E. Flanagan, A.-M. Patch, D. J. G. Mackay et al., "Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood, " Diabetes, vol. 56, no. 7, pp. 1930-1937, 2007.
17. M. Rafiq, S. E. Flanagan, A. M. Patch, B. M. Shields, S. Ellard, and A. T. Hattersley, "Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Neonatal Diabetes International Collaborative Group, " Diabetes Care, vol. 31, no. 2, pp. 204-209, 2008.
18. D. Carmody, C. D. Bell, J. L. Hwang et al., "Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons, " Journal of Clinical Endocrinology andMetabolism, vol. 99, no. 12, pp. E2709-E2714, 2014.
19. Y. Sang, M. Liu, W. Yang, J. Yan, Chengzhu, and G. Ni, "A novel EIF2AK3mutation leading toWolcott-Rallison syndrome in a Chinese child, " Journal of Pediatric Endocrinology & Metabolism, vol. 24, no. 3-4, pp. 181-184, 2011.
20. O. Massa, D. Iafusco, E. DAmato, A. L. Gloyn, A. T. Hattersley, and B. Pasquino, "KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Early onset diabetes study group of the Italian Society of Pediatric Endocrinology and Diabetology, " Human Mutation, vol. 25, pp. 22-27, 2005.
21. V. Labay, T. Raz, D. Baron et al., "Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness, " Nature Genetics, vol. 22, no. 3, pp. 300-304, 1999.
22. R. S. Wildin, S. Smyk-Pearson, and A. H. Filipovich, "Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome, " Journal of Medical Genetics, vol. 39, no. 8, pp. 537-545, 2002.
23. H. Demirbilek, V. B. Arya, M. N. Ozbek et al., "Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes from the South-Eastern region of Turkey: predominance of non-KATP channel mutations, " European Journal of Endocrinology, vol. 172, no. 6, pp. 697-705, 2015.
24. S. Jahnavi, V. Poovazhagi, S. Kanthimathi, V. Gayathri, V. Mohan, and V. Radha, "EIF2AK3 mutations in South Indian children with permanent neonatal diabetes mellitus associated withWolcott-Rallison syndrome, " PediatricDiabetes, vol. 15, no. 4, pp. 313-318, 2014.
25. P. Proks, C. Girard, S. Haider et al., "A gating mutation at the internal mouth of the Kir6. 2 pore is associated with DEND syndrome, " EMBO Reports, vol. 6, no. 5, pp. 470-475, 2005.